Yildirim Beyazit University, Faculty of Medicine, Ataturk Education and Research Hospital, Department of Endocrinology and Metabolism, Ankara, Turkey.
Yildirim Beyazit University, Faculty of Medicine, Ataturk Education and Research Hospital, Department of Endocrinology and Metabolism, Ankara, Turkey.
Asian J Surg. 2017 Sep;40(5):338-344. doi: 10.1016/j.asjsur.2015.10.006. Epub 2016 Jan 11.
Concomitant thyroid pathologies in patients with primary hyperparathyroidism (PHPT) present a challenge in the clinical and surgical decision-making for these patients. In this study, we aimed to evaluate concomitant thyroid pathologies in patients who underwent operations for PHPT to determine the sensitivity (Sn) of neck ultrasonography (US) and Tc99m sestamibi scintigraphy in detecting parathyroid adenoma. We also aimed to determine the clinical impact of preoperative neck US in patients with PHPT.
One hundred thirty-eight patients with PHPT were included in this retrospective study. All patients underwent preoperative Tc99m sestamibi scintigraphy and/or thyroid US. Nodules of ≥1 cm or <1 cm with suspicious US features underwent fine needle aspiration biopsy (FNAB).
Preoperative thyroid US revealed that 93.5% of patients with PHPT had thyroid abnormalities and 66.7% of patients had at least one thyroid nodule. Postoperative histopathology results showed that 79.2% of patients had benign thyroid disease and 20.8% of patients had malignant thyroid disease. In the detection of parathyroid adenoma, US had 89.1% Sn and Tc99m sestamibi scintigraphy had 82.6% Sn.
We recommend the routine use of US in combination with Tc99m sestamibi scintigraphy, especially in endemic goiter regions, to detect any concomitant thyroid disease and thus determine the best surgical strategy for patients with PHPT.
原发性甲状旁腺功能亢进症(PHPT)患者同时存在甲状腺疾病,这给这些患者的临床和手术决策带来了挑战。本研究旨在评估接受 PHPT 手术患者的同时存在的甲状腺疾病,以确定颈部超声(US)和 Tc99m sestamibi 闪烁扫描在检测甲状旁腺瘤中的敏感性(Sn)。我们还旨在确定 PHPT 患者术前颈部 US 的临床影响。
本回顾性研究纳入了 138 例 PHPT 患者。所有患者均接受了 Tc99m sestamibi 闪烁扫描和/或甲状腺 US 检查。结节≥1cm 或<1cm 且具有可疑 US 特征的患者行细针抽吸活检(FNAB)。
术前甲状腺 US 显示 93.5%的 PHPT 患者存在甲状腺异常,66.7%的患者存在至少一个甲状腺结节。术后组织病理学结果显示,79.2%的患者存在良性甲状腺疾病,20.8%的患者存在恶性甲状腺疾病。在检测甲状旁腺瘤方面,US 的 Sn 为 89.1%,Tc99m sestamibi 闪烁扫描的 Sn 为 82.6%。
我们建议常规使用 US 联合 Tc99m sestamibi 闪烁扫描,特别是在地方性甲状腺肿地区,以检测任何同时存在的甲状腺疾病,从而为 PHPT 患者确定最佳手术策略。